Hexagon Capital Partners’s Tenet Healthcare THC Stock Holding History

Hexagon Capital Partners’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-200	Closed	-$26.9K	–	1554
2025 Q1	$26.9K	Hold	200	–	–	0.01%	647
2024 Q4	$25.2K	Hold	200	–	–	﹤0.01%	703
2024 Q3	$33.2K	Hold	200	–	–	0.01%	540
2024 Q2	$26.6K	Hold	200	–	–	0.01%	591
2024 Q1	$21K	Hold	200	–	–	﹤0.01%	660
2023 Q4	$15.1K	Hold	200	–	–	﹤0.01%	728
2023 Q3	$13.2K	Hold	200	–	–	﹤0.01%	669
2023 Q2	$16.3K	Hold	200	–	–	﹤0.01%	613
2023 Q1	$11.9K	Hold	200	–	–	﹤0.01%	690
2022 Q4	$9.76K	Sell	200 -1,000	-83%	-$46.2K	﹤0.01%	735
2022 Q3	$62K	Hold	1,200	–	–	0.02%	328
2022 Q2	$63K	Hold	1,200	–	–	0.02%	328
2022 Q1	$103K	Hold	1,200	–	–	0.03%	270
2021 Q4	$98K	Hold	1,200	–	–	0.03%	274
2021 Q3	$80K	Hold	1,200	–	–	0.02%	278
2021 Q2	$80K	Hold	1,200	–	–	0.02%	274
2021 Q1	$62K	Hold	1,200	–	–	0.02%	284
2020 Q4	$47K	Sell	1,200 -5,300	-82%	-$171K	0.01%	276
2020 Q3	$173K	Buy	+6,500	New	+$166K	0.06%	122

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Hexagon Capital Partners's THC Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 200 shares — an estimated $26.9K sold.

Hexagon Capital Partners first reported a position in THC in Q3 2020 and held it in 19 quarters. The position peaked at $173K in Q3 2020. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

Hexagon Capital Partners reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
Hexagon Capital Partners sold 200 Tenet Healthcare shares in Q2 2025, an estimated $26.9K.
Hexagon Capital Partners first reported a position in Tenet Healthcare in Q3 2020 and held it in 19 quarters.
Hexagon Capital Partners's Tenet Healthcare position peaked at $173K in Q3 2020.
626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.